Medicare Recipients to See Lower Prescription Drug Costs

OAN Newsroom
UPDATED 6:35 AM PT — Fri. February 9, 2018

The Trump administration is laying out plans to lower prescription drug prices for Medicare recipients.

A senior White House official detailed the president’s proposal, saying it will allow seniors covered under Medicare Part D to share the Big Pharma rebates.

Currently, the rebates are paid by drug-makers to insurers and pharmacies, who maintain a stable market demand for the Big Pharma.

FILE PHOTO: Bottles of medications line the shelves at a pharmacy in Portsmouth, Ohio, U.S. on June 21, 2017. (REUTERS/Bryan Woolston/File Photo)

The president’s plan is set to not only reduce drug costs, but will also make outpatient procedures cheaper.

Experts say while President Trump’s proposal is good for Medicare recipients, pharmacies and insurers might respond by raising rates.